AMY SHIRLEY: Open Payments
NPI 1770068330 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,726 in 92 payments from 28 companies in 2025. Trend: 2023 $1,115 · 2024 $1,531 · 2025 $1,726
Food & beverage: $1,726
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $398 |
| AstraZeneca Pharmaceuticals LP | 11 | $228 |
| Lilly USA, LLC | 8 | $124 |
| Verona Pharma, Inc. | 4 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| Abbott Laboratories | 2 | $68 |
| Amgen Inc. | 4 | $60 |
| Corium, LLC | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Phathom Pharmaceuticals, Inc. | 5 | $55 |
Products named: LINZESS, MOUNJARO, UBRELVY, FARXIGA, Ohtuvayre, AIRSUPRA, Azstarys, REXULTI.
Industry payments across TX — which companies pay providers there.
